Susan Hogan to Prevalence
This is a "connection" page, showing publications Susan Hogan has written about Prevalence.
Connection Strength
0.200
-
Gibson KL, Gipson DS, Massengill SA, Dooley MA, Primack WA, Ferris MA, Hogan SL. Predictors of relapse and end stage kidney disease in proliferative lupus nephritis: focus on children, adolescents, and young adults. Clin J Am Soc Nephrol. 2009 Dec; 4(12):1962-7.
Score: 0.059
-
Reynolds ML, Loehr LR, Hogan SL, Hu Y, Isasi CR, Cordero C, Ricardo AC, Lash JP, Derebail VK. Prevalence of infertility and pregnancy loss among individuals with kidney disease in the Hispanic Community Health Study/Study of Latinos. Womens Health (Lond). 2024 Jan-Dec; 20:17455057231224544.
Score: 0.040
-
Strasma A, Reyes ?M, Arag?n A, L?pez I, Park LP, Hogan SL, Thielman N, Wyatt C, Gonz?lez-Quiroz M. Kidney disease characteristics, prevalence, and risk factors in Le?n, Nicaragua: a population-based study. BMC Nephrol. 2023 11 12; 24(1):335.
Score: 0.039
-
O'Shaughnessy MM, Hogan SL, Thompson BD, Coppo R, Fogo AB, Jennette JC. Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey. Nephrol Dial Transplant. 2018 04 01; 33(4):661-669.
Score: 0.027
-
Mottl AK, Kwon KS, Mauer M, Mayer-Davis EJ, Hogan SL, Kshirsagar AV. Normoalbuminuric diabetic kidney disease in the U.S. population. J Diabetes Complications. 2013 Mar-Apr; 27(2):123-7.
Score: 0.018
-
Roth AJ, Brown MC, Smith RN, Badhwar AK, Parente O, Chung Hc, Bunch DO, McGregor JG, Hogan SL, Hu Y, Yang JJ, Berg EA, Niles J, Jennette JC, Preston GA, Falk RJ. Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis. J Am Soc Nephrol. 2012 Mar; 23(3):545-55.
Score: 0.017